Bacillus Coagulans
Also known as: B. coagulans, Lactobacillus sporogenes (historical), BC30, GBI-30
The spore-forming probiotic that survives the stomach — evidenced for IBS-type symptoms and antibiotic-associated diarrhea.
In short
Bacillus coagulans is a spore-forming, lactic-acid-producing bacterium used as a probiotic. Its defining feature is the spore: a tough shell that protects it through stomach acid and shelf storage, so it arrives in the intestine alive — a survival problem that plagues many Lactobacillus and Bifidobacterium products. Well-studied branded strains (notably GBI-30, marketed as BC30) have randomized-trial evidence for reducing abdominal pain and bloating in IBS-type conditions, preventing antibiotic-associated diarrhea, and supporting immune markers. It is generally recognized as safe, including in children, and unlike some probiotics, needs no refrigeration.
- Spore-forming probiotic; survives stomach acid and shelf storage
- No refrigeration needed; spores germinate in the gut
- Trial evidence: IBS-type pain/bloating, antibiotic-associated diarrhea
- Branded strains (BC30/GBI-30) carry most of the evidence
What is Bacillus Coagulans?
Most probiotics die on the way to your gut — stomach acid is merciless, and heat-killed capsules are a known industry problem. Bacillus coagulans solves this with evolution's answer to hostile environments: it forms a spore. The dormant spore shrugs off acid and room-temperature shelves, then germinates into active bacteria in the small intestine, producing lactic acid and outcompeting troublemakers. That hardiness has made it a favorite of formulators and, increasingly, of clinical researchers — with branded strains accumulating real trial data for gut comfort and antibiotic-related diarrhea.
Where it comes from
Natural sources
- Spore-forming, lactic-acid-producing bacterium found in soil and fermented foods
- Historically mislabeled 'Lactobacillus sporogenes'
- Commercial strains: GBI-30 (BC30), SNZ 1969, and others
How it's made
Cultured and dried as spores in capsules and gummies; typical doses 1–10 billion CFU.
What it does in products
Benefits
IBS-type abdominal pain and bloating
moderate evidenceRandomized trials with GBI-30 report reduced abdominal pain, bloating, and improved bowel regularity in people with IBS-type symptoms.
Antibiotic-associated diarrhea prevention
moderate evidenceTrials in adults and children find fewer diarrhea episodes when B. coagulans is taken alongside antibiotics.
Immune and gut-barrier support
emerging evidenceSome trials show improved immune markers and reduced respiratory symptoms; evidence is promising but less mature.
Side effects & safety
Safety considerations
- Generally recognized as safe; used in trials in children and pregnant women without serious events, though data remain limited.
- Antibiotics — may reduce live-cell delivery if taken simultaneously; separate doses by 2+ hours
- Immunosuppressants — theoretical risk with any live microbe; seek medical advice
- Not for: Severe immunocompromise
- Not for: Central venous catheters (generic probiotic precaution)
How it's used
In supplements
1–2 billion CFU/day for gut maintenance; up to 10 billion CFU/day in some trials. Store per label (spores tolerate room temperature).
In skincare
Not a topical ingredient.
Regulatory status
- Sold as a dietary supplement; GRAS status granted for specific strains in foods.
- GRAS (generally recognized as safe) for food use.
- Not applicable.
Popular products containing Bacillus Coagulans
- Schiff Digestive Advantage (BC30) — GBI-30 strain capsulesSchiff · Supplement
- Culturelle Digestive Daily Probiotic (varies by product) — Some SKUs feature BC30Culturelle · Supplement
- Thorne FloraSport 20B — Includes B. coagulans sporesThorne · Supplement
Product names and brands are shown for reference and belong to their respective owners.
Why spores change the math
Conventional probiotics rely on freeze-dried vegetative cells that must survive transit. Spores, by contrast, are dormant structures with 10–50% delivery rates to the gut versus single-digit percentages for many vegetative strains. The same stability lets B. coagulans be baked into bars and gummies — a rare probiotic that survives food processing.
Strain notes
Most clinical data attach to GBI-30, 6086 (BC30). Other commercial strains (SNZ 1969, Unique IS-2) have their own smaller dossiers. As with all probiotics, results should be read strain-specifically, and product labels should name the exact strain and count.
Frequently asked questions
Does Bacillus coagulans need refrigeration?
No — the spore form is stable at room temperature, which is one of its main practical advantages.
Is it the same as Lactobacillus sporogenes?
Historically it was misclassified under that name. B. coagulans is the correct taxonomy; old labels occasionally still say 'sporogenes'.
Can I take it every day?
Yes — daily use is the studied pattern, with no signals of dependence or diminishing tolerance in long-term trials.
The bottom line
Bacillus coagulans is a practical, evidence-supported probiotic whose spore hardiness solves the survival problem — with trial backing for IBS-type symptoms and antibiotic-associated diarrhea.
References
- Bacillus coagulans GBI-30: clinical evidence review. PubMed Central. https://pubmed.ncbi.nlm.nih.gov/26670070/
- Bacillus coagulans for functional abdominal symptoms. World Journal of Gastrointestinal Pharmacology and Therapeutics. https://pubmed.ncbi.nlm.nih.gov/27648428/
- Probiotics — Health Professional Fact Sheet. NIH Office of Dietary Supplements. https://ods.od.nih.gov/factsheets/Probiotics-HealthProfessional/